Helius
-
NZ doctors’ interest in medicinal cannabis grows
A leading medicinal cannabis online education platform is encouraged by the strong interest it’s now seeing from New Zealand’s key…
Read More » -
First key ‘Cannabis for pets’ study conducted
A New Zealand company that’s set to be among the first in the world to register cannabis medicines for pets…
Read More » -
Helius appoints Director of R&D
Marten Vos has been appointed Director of Research & Development at Helius Therapeutics. “Helius is squarely focused on building and…
Read More » -
Candace Kinser appointed chair of Helius Therapeutics
Candace Kinser has been appointed chair of the board at Helius Therapeutics. The accomplished chief executive and non-executive board director…
Read More » -
Helius celebrates female leadership in cannabis sector
Helius Therapeutics is taking time to reflect on Suffrage Day. On 19 September 1893, New Zealand became the first nation in…
Read More » -
Helius forms advanced medicinal cannabis collaboration
New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has signed an agreement with Auckland University of Technology (AUT). It will see Helius working with…
Read More » -
Helius gains NZ’s first licence to manufacture cannabis medicines
New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by…
Read More »
